Acutus Medical, Inc. (AFIB)
OTCMKTS
· Delayed Price · Currency is USD
0.0540
0.00 (0.00%)
Feb 21, 2025, 3:00 PM EST
Acutus Medical Revenue
Acutus Medical had revenue of $5.27M in the quarter ending September 30, 2024, with 155.63% growth. This brings the company's revenue in the last twelve months to $15.38M, down -532.61% year-over-year. In the year 2023, Acutus Medical had annual revenue of $7.16M with 136.36% growth.
Revenue (ttm)
15.38M
Revenue Growth
-532.61%
P/S Ratio
0.10
Revenue / Employee
66.27K
Employees
233
Market Cap
1.60M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
SS Innovations International | 16.04M |
Veradigm | 1.53B |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
Silence Therapeutics | 21.77M |
SANUWAVE Health | 29.30M |
Acutus Medical News
- 2 months ago - Acutus Medical announces workforce reduction by 70% - Seeking Alpha
- 2 months ago - Acutus Medical Announces Operational Downsizing - GlobeNewsWire
- 3 months ago - Acutus Medical GAAP EPS of -$0.03 - Seeking Alpha
- 3 months ago - Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results - GlobeNewsWire
- 7 months ago - Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial Results - GlobeNewsWire
- 10 months ago - Acutus Medical Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 11 months ago - Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 1 year ago - Top 4 Health Care Stocks That Could Blast Off This Quarter - Acutus Medical (NASDAQ:AFIB), Becton Dickinson (NYSE:BDX) - Benzinga